Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Karolinska Institutet Childrens Research Institute |
---|---|
Information provided by: | Karolinska Institutet |
ClinicalTrials.gov Identifier: | NCT00519103 |
The aim of this study was to investigate the effects of physical exercise on gene expression in muscle biopsies from patients with chronic polymyositis or dermatomyositis
Condition | Intervention |
---|---|
Myositis Exercise |
Other: exercise |
Study Type: | Interventional |
Study Design: | Basic Science, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Enrollment: | 8 |
Study Start Date: | December 2002 |
Study Completion Date: | March 2003 |
Arms | Assigned Interventions |
---|---|
1: Experimental
Active resistive excercise for 7 weeks
|
Other: exercise |
Eight patients with polymyositis or dermatomyositis according to the Bohan and Peter criteria and who had all participated in a resistive exercise trial at Karolinska University Hospital, Stockholm, Sweden, were included in this study. Patients were included if they had a disease duration more than 12 months and they had to have a stable, low disease activity and medication for three months before enrollment in the study. Patients with inclusion body myositis were excluded as well as patients with co morbidities that contradicted vigorous exercise (severe osteoporosis with multiple fractures, malignant disease severe lung disease) or if they were physically active more than once a week. The median disease duration at time of study start was 4.5 years (range 2,7-29 year). All patients had been treated with glucocorticoids and other immunosuppressive therapies with some improvement of muscle function but with persisting muscle impairment. At time of study seven patients were still on immunosuppressive treatment, five were taking prednisone with a median dosage of 2.5 mg/day (range 0-6.25 mg/d). Six patients were treated with azathioprine, one in combination with cyclosporine A, one patient was treated with methotrexate and one with IVIG 2g/kg body weight every three months
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Sweden | |
Rheumatology unit, Karolinska Unirversity hospital | |
Stockholm, Sweden |
Principal Investigator: | Ingrid E Lundberg, MD, PhD | Rheumatology Unit, Department of Medicine, in Solna, Karolinska Institutet |
Study ID Numbers: | Lundberg-1 |
Study First Received: | August 20, 2007 |
Last Updated: | August 29, 2007 |
ClinicalTrials.gov Identifier: | NCT00519103 |
Health Authority: | Sweden: Institutional Review Board |
microarray Inflammtion fibrosis |
Myositis Muscular Diseases Neuromuscular Diseases Musculoskeletal Diseases |
Fibrosis Idiopathic myopathy Inflammation |
Nervous System Diseases |